Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Morbidity associated with three different antiplatelet regimens in patients undergoing implantation of cardiac rhythm management devices.

Cano O, Osca J, Sancho-Tello MJ, Olagüe J, Castro JE, Salvador A.

Europace. 2011 Mar;13(3):395-401. doi: 10.1093/europace/euq431. Epub 2010 Dec 4.

PMID:
21131650
2.

Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.

Tompkins C, Cheng A, Dalal D, Brinker JA, Leng CT, Marine JE, Nazarian S, Spragg DD, Sinha S, Halperin H, Tomaselli GF, Berger RD, Calkins H, Henrikson CA.

J Am Coll Cardiol. 2010 May 25;55(21):2376-82. doi: 10.1016/j.jacc.2009.12.056.

3.

Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation.

Chen HC, Chen YL, Guo BF, Tsai TH, Chang JP, Pan KL, Lin YS, Chen MC.

Can J Cardiol. 2013 Sep;29(9):1110-7. doi: 10.1016/j.cjca.2012.12.014. Epub 2013 Mar 6.

PMID:
23474139
4.

Use of oxidized regenerated cellulose to prevent pocket hematomas after cardiac electronic device implantation in patients on anticoagulants or dual antiplatelet therapy.

Chia PL, Foo D.

Int J Cardiol. 2013 Oct 9;168(4):4406-7. doi: 10.1016/j.ijcard.2013.05.037. Epub 2013 May 22. No abstract available.

PMID:
23706282
5.

The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation.

Thal S, Moukabary T, Boyella R, Shanmugasundaram M, Pierce MK, Thai H, Goldman S.

Pacing Clin Electrophysiol. 2010 Apr;33(4):385-8. doi: 10.1111/j.1540-8159.2009.02674.x. Epub 2010 Jan 4.

PMID:
20059711
6.

Risk of hematoma complications after device implant in the clopidogrel era.

Kutinsky IB, Jarandilla R, Jewett M, Haines DE.

Circ Arrhythm Electrophysiol. 2010 Aug;3(4):312-8. doi: 10.1161/CIRCEP.109.917625. Epub 2010 Jun 17.

7.

Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios.

Ghanbari H, Feldman D, Schmidt M, Ottino J, Machado C, Akoum N, Wall TS, Daccarett M.

Pacing Clin Electrophysiol. 2010 Apr;33(4):400-6. doi: 10.1111/j.1540-8159.2010.02703.x. Epub 2010 Feb 18.

PMID:
20180915
8.

Risk factors associated with bleeding after multi antithrombotic therapy during implantation of cardiac implantable electronic devices.

Ishibashi K, Miyamoto K, Kamakura T, Wada M, Nakajima I, Inoue Y, Okamura H, Noda T, Aiba T, Kamakura S, Shimizu W, Yasuda S, Akasaka T, Kusano K.

Heart Vessels. 2017 Mar;32(3):333-340. doi: 10.1007/s00380-016-0879-x. Epub 2016 Jul 28.

9.

Anticoagulation and antiplatelet therapy in implantation of electrophysiological devices.

Korantzopoulos P, Letsas KP, Liu T, Fragakis N, Efremidis M, Goudevenos JA.

Europace. 2011 Dec;13(12):1669-80. doi: 10.1093/europace/eur210. Epub 2011 Jul 25. Review.

PMID:
21788280
10.

A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation.

Michaud GF, Pelosi F Jr, Noble MD, Knight BP, Morady F, Strickberger SA.

J Am Coll Cardiol. 2000 Jun;35(7):1915-8.

11.

Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI).

Deharo JC, Sciaraffia E, Leclercq C, Amara W, Doering M, Bongiorni MG, Chen J, Dagres N, Estner H, Larsen TB, Johansen JB, Potpara TS, Proclemer A, Pison L, Brunet C, Blomström-Lundqvist C; Coordinated by the Scientific Initiatives Committee of the European Heart Rhythm Association.

Europace. 2016 May;18(5):778-84. doi: 10.1093/europace/euw127.

PMID:
27226497
12.

Implantation of cardiac rhythm devices during concomitant anticoagulation or antiplatelet therapy.

Ramirez A, Wall TS, Schmidt M, Selzman K, Daccarett M.

Expert Rev Cardiovasc Ther. 2011 May;9(5):609-14. doi: 10.1586/erc.11.48. Review.

PMID:
21615324
13.

Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide.

Jamula E, Douketis JD, Schulman S.

J Thromb Haemost. 2008 Oct;6(10):1615-21. doi: 10.1111/j.1538-7836.2008.03080.x. Epub 2008 Jul 12. Review.

14.

Cardiac rhythm management devices (part II): perioperative management.

Atlee JL, Bernstein AD.

Anesthesiology. 2001 Dec;95(6):1492-506. Review. No abstract available.

PMID:
11748411
15.

Diagnosis and management of infections involving implantable electrophysiologic cardiac devices.

Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM.

Ann Intern Med. 2000 Oct 17;133(8):604-8.

PMID:
11033588
16.

Retroperitoneal hematoma in patients undergoing cardiac catheterization.

Frank JJ, Kamalakannan D, Kodenchery M, Savoy-Moore RT, Rosman H.

J Interv Cardiol. 2010 Dec;23(6):569-74. doi: 10.1111/j.1540-8183.2010.00583.x. Epub 2010 Aug 27.

PMID:
20796167
17.

Oral anticoagulation continuation compared with heparin bridging therapy among high risk patients undergoing implantation of cardiac rhythm devices: a meta-analysis.

Feng L, Li Y, Li J, Yu B.

Thromb Haemost. 2012 Dec;108(6):1124-31. doi: 10.1160/TH12-07-0498. Epub 2012 Oct 10. Review.

PMID:
23051884
18.

Complications arising from cardiac implantable electrophysiological devices: review of epidemiology, pathogenesis and prevention for the clinician.

Atreya AR, Cook JR, Lindenauer PK.

Postgrad Med. 2016;128(2):223-30. doi: 10.1080/00325481.2016.1151327. Epub 2016 Feb 22. Review.

PMID:
26849147
19.

Complications of pacemakers and defibrillators in the elderly.

Bailey SM, Wilkoff BL.

Am J Geriatr Cardiol. 2006 Mar-Apr;15(2):102-7. Review.

PMID:
16525223
20.

Supplemental Content

Support Center